StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
6-factor scoring with sector-relative rank. Updated daily.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-12 | $18.74 | $19.19 | +2.40% | 0.1M |
| 05-13 | $19.12 | $18.67 | -2.35% | 0.1M |
| 05-14 | $18.78 | $18.93 | +0.80% | 0.1M |
| 05-15 | $18.87 | $18.62 | -1.32% | 0.1M |
| 05-18 | $18.55 | $18.74 | +1.02% | 0.1M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
No sell-side coverage available for NRC.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $34.80M | $137.39M | $102.20M | $67.59M |
Operating Income | $5.57M | $22.59M | $17.92M | $10.18M |
Net Income | $3.22M | $11.60M | $9.80M | $-106.00K |
EPS (Diluted) | $0.14 | $50.00 | $0.43 | $0.25 |
Total Assets | $134.56M | $134.88M | $135.72M | $141.39M |
Total Liabilities | $121.06M | $120.89M | $121.41M | $120.06M |
Cash & Equivalents | $2.55M | $4.14M | $2.22M | $5.27M |
Free Cash Flow OCF − CapEx | $5.35M | $15.74M | $9.69M | $-489.00K |
Shares Outstanding | 22.54M | 22.64M | 22.66M | 23.10M |